Tiara N. Brown-Crosen

FDA investigator · also recorded as Ats Tiara N. Brown-Crosen, As Tiara N. Brown-Crosen

Appears on 7 documents from 2016 to 2019, most often at sites in Missouri. Most often cites stability testing (21 CFR 211.166).

7
Documents on file
3.4
Observations per 483
2016
First seen
2019
Most recent

What they cite most

From 24 observations

Activity by year

2016: 1, 2017: 3, 2018: 2, 2019: 1

Where

Missouri 3 · India 2 · Illinois 1 · Switzerland 1

Is Tiara N. Brown-Crosen coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 Sentio BioSciences LLCApr 19, 2019 · Maryland Heights, Missouri
483 Lee Pharma LimitedNov 2, 2018 · Sangareddy, India
483 HomeChoice Partners, Inc. dba BioscripSep 19, 2018 · Chesterfield, Missouri
483 Lonza AGDec 15, 2017 · Visp, Switzerland
483 Form 483 · FEI 1972829Nov 16, 2017 · Fenton, Missouri
483 Central Illinois Compounding, Inc. dba Preckshot Professional PharmacySep 19, 2017 · Peoria, Illinois
483 Alkem Laboratories LtdSep 29, 2016 · Daman, India

About this profile

What does Tiara N. Brown-Crosen inspect?

Tiara N. Brown-Crosen appears on 7 documents on file covering 7 sites, most often in Missouri.

What do they cite most often?

21 CFR 211.166 (stability testing), followed by 21 CFR 211.42 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Tiara N. Brown-Crosen is dated Apr 19, 2019.